Photodynamic therapy (PDT) is a clinically approved cancer therapy, based on a
photochemical reaction between a light activatable molecule or photosensitizer, light, and …

Photodynamic therapy (PDT) uses light-activated drugs to treat diseases ranging from
cancer to age-related macular degeneration and antibiotic-resistant infections. This paper …

The development of probes for early monitoring tumor therapy response may greatly benefit
the promotion of photodynamic therapy (PDT) efficacy. Singlet oxygen (1O2) generation is a …

Photodynamic therapy (PDT) uses photosensitizers and visible light in combination with
molecular oxygen to produce reactive oxygen species (ROS) that kill malignant cells by …

Photodynamic therapy (PDT) involves the administration of photosensitizer followed by local
illumination with visible light of specific wavelength (s). In the presence of oxygen molecules …

Photodynamic therapy (PDT) is an emerging treatment modality that employs the
photochemical interaction of three components: light, photosensitizer, and oxygen …

Abstract Singlet oxygen (1O2) is the major cytotoxic agent responsible for cell killing for type‐
II photodynamic therapy (PDT). An empirical four‐parameter macroscopic model is …

Photosensitizer photochemical parameters are crucial data in accurate dosimetry for
photodynamic therapy (PDT) based on photochemical modeling. Progress has been made …

Purpose: In superficial basal cell carcinomas treated with photodynamic therapy with topical
δ-aminolevulinic acid, we examined effects of light irradiance on photodynamic efficiency …

Abstract Background and Objectives Photodynamic therapy (PDT) with porfimer sodium,
FDA approved to treat premalignant lesions in Barrett's esophagus, causes photosensitivity …